Advisor Group Holdings, Inc. Altamira Therapeutics Ltd. Transaction History

Advisor Group Holdings, Inc.

  • $42.2 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 10, 2022
BUY
$0.48 - $1.66 $144 - $498
300 Added 3000.0%
310 $0
Q1 2022

May 04, 2022
SELL
$0.69 - $1.92 $1,328 - $3,697
-1,926 Reduced 99.48%
10 $0
Q3 2021

Nov 05, 2021
BUY
$2.01 - $3.58 $3,891 - $6,930
1,936 New
1,936 $4,000

About Altamira Therapeutics Ltd.

CYTO Quotes by TradingView
  • Ticker CYTO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 1,009,710
  • Market Cap $172K
  • Description
  • Altamira Therapeutics Ltd. engages in developing therapeutics that address various unmet medical needs. Its commercial products include Bentrio, a drug-free nasal spray for personal protection against airborne viruses and allergens. The company is also involved in the development of RNA therapeutics for extrahepatic therapeutic targets, includin...
More about CYTO
Track This Portfolio

Track Advisor Group Holdings, Inc. Portfolio

Follow Advisor Group Holdings, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Advisor Group Holdings, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email